FDA Entry Point vs Assurentry: Full-Stack Agent vs Self-Service

Introduction

Foreign manufacturers comparing FDA Entry Point and Assurentry are not simply choosing between $295 and $199 annual prices. They are choosing an operating model: a human-led, full-stack FDA compliance firm with one accountable team, or a platform-led service built around guided workflows, a dashboard, compliance tools, and specialist filing support.

That distinction matters because an FDA U.S. Agent is a working regulatory contact, not merely a name entered into a form. For foreign food facilities, FDA treats information delivered to the U.S. Agent as delivered to the facility; for medical devices, the role includes communications, questions about imported devices, and inspection scheduling. FDA food-facility guidance and FDA medical-device guidance define those responsibilities.

Key takeaways

Assurentry has the lower advertised price and stronger self-service layer. Its public pricing lists U.S. Agent service at $199 per year, a dashboard, renewal reminders, food registration, and more than 30 compliance tools.
FDA Entry Point is not a minimalist or mailbox-only service. The $295 annual relationship includes active FDA communication handling, inspection coordination, renewal tracking, and direct specialist support, with registration, Prior Notice, label review, SPL, and GUDID/UDI work available through the same team.
The headline difference is $96 per year, or $8 per month. Buyers should decide whether that saving outweighs the value of a named human team that can perform adjacent compliance work rather than primarily routing it through a platform.
Assurentry’s public pricing needs contract-level reconciliation. Its pricing page advertises $199 per year, while its October 7, 2025 terms set a default U.S. Agent fee of $399 per year unless an order states otherwise. The executed order must therefore confirm the actual price.
Assurentry publishes the stronger emergency SLA. It commits to under four business hours for priority FDA communications and under two business hours for inspection or import-hold notices; FDA Entry Point publishes a response commitment of 24 business hours.

Evidence: FDA Entry Point U.S. Agent services, Assurentry pricing, Assurentry terms, and Assurentry service-level agreement.

FDA Entry Point and Assurentry side by side

Public pricing and scope reviewed September 18, 2026: FDA Entry Point pricing; Assurentry pricing; Assurentry terms.
Decision dimension	FDA Entry Point	Assurentry
Operating model	Human-led, full-stack FDA compliance firm with one accountable team.	Platform-led model combining guided intake, self-service tools, a dashboard, and a filing team.
Advertised annual U.S. Agent price	$295 per year.	$199 per year on the pricing page; public terms set $399 per year unless the order states otherwise.
FDA communications	Receipt and escalation of official communications, inspection coordination, and help coordinating the required response.	FDA mail forwarding, inspection escalation, portal tracking, and defined priority and emergency response targets.
Renewal model	Proactive renewal tracking and coordination under the continuing relationship.	Automated reminders at 90, 60, and 30 days before the renewal window.
Registration and filing execution	Separately priced registration, product listing, Prior Notice, label review, SPL, NDC, and GUDID/UDI execution across food, cosmetics, drugs, and devices.	Food registration is included in the advertised agent plan; food-import and cosmetics workflows have published plans. Drug and medical-device workflow plans are listed as coming soon.
Self-service technology	Not dashboard-centered; the primary interface is the specialist team.	Full dashboard, online onboarding, status tracking, and more than 30 compliance tools.
Response commitment	Within 24 business hours for U.S. Agent and compliance questions.	Under 24 business hours for standard inquiries, under four for priority FDA communications, and under two for inspection or import-hold emergencies.
Stronger fit	Buyers who need an accountable human team to own communications and perform adjacent compliance work.	Buyers prioritizing the lowest advertised price, digital visibility, and self-service tools.

What is included—and what should not become a surprise fee

The clean comparison is not “$295 versus $199.” It is the recurring agent fee plus every registration, product, shipment, renewal, response, and exit charge that the buyer will actually incur.

Line items compiled from FDA Entry Point’s 2026 pricing analysis, Assurentry’s public plans, and Assurentry’s legal scope.
Cost or service	FDA Entry Point	Assurentry	What the buyer should confirm
Annual U.S. Agent coverage	$295 per facility per year.	$199 per year on the pricing page; $399 is the default in the public terms unless changed by the order.	The exact first-year and renewal price written into the executed order.
FDA communication handling	Included: receipt, escalation, inspection coordination, renewal tracking, and direct specialist support.	Included: mail forwarding, inspection escalation, renewal reminders, dashboard access, and SLA-based routing.	Whether analysis, response drafting, corrective work, or enforcement support is included or separately scoped.
Food facility registration	$249 per filing; separate from the annual agent fee.	Included with the advertised $199 U.S. Agent plan.	Whether amendments, biennial renewals, DUNS/UFI corrections, and ownership changes are part of the quoted registration scope.
Prior Notice	$30 per filing. Standing U.S. Agent coverage has no per-shipment charge.	The separately named $199 Food Importer Bundle lists Prior Notice preparation and filing. Assurentry’s general U.S. Agent terms exclude Prior Notice from the base agent service.	Which plan applies and whether multi-product shipments create additional billable filings.
Label review	Food label review starts at $249 per product; cosmetic, drug, and device reviews start at $449 per product.	An AI label scan is advertised at $29 per scan. A price for broader human regulatory review is not publicly available.	Whether the service covers ingredients, formatting, claims, revision rounds, and final human review.
Cosmetics and MoCRA	U.S. Agent service is $295; facility registration, product listing, label review, and Responsible Person support are separately scoped.	The $299 Cosmetics plan lists facility registration and product-listing operations.	Whether Assurentry’s $299 cosmetics subscription includes U.S. Agent designation or requires the separate agent plan.
Drug and medical-device operations	Public prices cover establishment registration, product or device listing, SPL, and label review.	The pricing page lists drug and medical-device operational plans as coming soon, although U.S. Agent representation covers all four categories under its terms.	Whether the required filing workflow is commercially available now, rather than merely listed in the broader service catalog.
Renewal and cancellation	The next agent term is $295 at the current rate. No separate agent-renewal surcharge or standalone cancellation fee appears on the published schedule; written termination stops future renewal.	The pricing page says “cancel anytime.” Fees become non-refundable after onboarding and issuance of the acceptance letter; renewal follows the order.	The notice method, renewal price, effective termination date, refund treatment, and transfer process.

The real dividing line: portal access or accountable execution

Assurentry is not a mailbox-only provider. Its current service model includes FDA communication routing, inspection escalation, a published SLA, guided intake, filing support, and a substantial digital toolset. For a regulatory manager who wants centralized visibility and is comfortable validating the platform’s output, that is a genuine advantage.

FDA Entry Point is also not the “basic agent service” implied by a price-and-tool-count comparison. It combines the standing agent role with an available operating team for registration, listings, label review, Prior Notice, SPL, and device-data submissions across four verticals. Those adjacent services are separately priced, but buyers do not have to locate and coordinate a new provider whenever the requirement moves beyond receiving an email. FDA Entry Point’s full-stack service scope documents that model.

A pattern worth naming is visibility versus ownership. A dashboard can show a deadline or flag a requirement; an accountable compliance team performs the filing, checks the product context, explains the notice, and coordinates the next action. Buyers with experienced internal regulatory staff can use visibility efficiently. Buyers without that staff usually need ownership.

FDA Entry Point is the stronger choice when

The founder or operations lead has no dedicated U.S. regulatory hire. The buyer needs the compliance work performed, not another interface that still leaves them responsible for interpreting every requirement.
The company has already been burned by a missed renewal, buried notice, or unresponsive low-cost agent. The practical need is one accountable team that receives, escalates, explains, and coordinates FDA-facing work.
Drug, device, or multi-vertical work is involved. FDA Entry Point already publishes operational support and pricing for drug registration, SPL, device registration, listing, and labeling, while Assurentry’s standard drug and device workflow plans remain on its waitlist.
The buyer wants line-item budget visibility. Registration, Prior Notice, product listing, SPL, and label-review prices are separated from the $295 recurring U.S. Agent fee rather than described as an undefined all-inclusive package.
The business wants one relationship across food, cosmetics, drugs, and medical devices. This reduces handoffs when a product portfolio crosses FDA centers or requires more than agent designation.

Foreign manufacturers replacing an underperforming provider can use the FDA U.S. Agent switching playbook to plan the transfer without creating a coverage gap.

Assurentry is the stronger choice when

The lowest advertised annual price is the deciding factor. The public $199 offer is $96 below FDA Entry Point, provided the executed order confirms that amount rather than the $399 default in Assurentry’s terms.
The buyer prefers a self-service dashboard. Assurentry provides digital onboarding, status tracking, downloadable documents, automated reminders, and more than 30 compliance tools.
A straightforward food registration is the immediate requirement. The advertised U.S. Agent plan includes food facility registration, which FDA Entry Point prices separately.
A formal emergency-response SLA matters more than a boutique human-liaison model. Assurentry publishes faster targets for priority FDA communications, inspection requests, and import-hold notices.

Assurentry’s platform model is most compelling when the buyer has enough internal regulatory capacity to review inputs, distinguish automated checks from final compliance decisions, and confirm exactly which filings and support services the selected plan includes. Assurentry’s service catalog outlines its platform and filing-team model.

Recommendation

FDA Entry Point is the more practical choice for foreign manufacturers that want one accountable human team to own U.S. Agent communications and execute the registration, listing, labeling, submission, and renewal work around them. The additional advertised cost is $8 per month, and the company publishes what adjacent work costs rather than pretending every compliance obligation is included in the annual agent fee.

Assurentry is a credible lower-price alternative for buyers who actively want a technology-led experience. Its dashboard, tools, food-registration inclusion, and emergency SLA are real strengths. Before purchasing, however, buyers should reconcile its $199 advertised fee with the $399 default in its public terms and put every included filing, renewal price, cancellation right, and add-on into the executed order.

Frequently asked questions

Is a cheap FDA U.S. Agent worth the risk?

A cheap FDA U.S. Agent can be economical when an experienced internal regulatory team already owns every registration, product listing, renewal, shipment filing, and FDA response. It is usually the wrong tradeoff for a founder or stretched operations lead who expects the agent to explain notices and perform compliance work. The relevant comparison is the total operating scope, not the name-on-form price. The 2026 FDA U.S. Agent buyer’s guide provides a due-diligence framework.

How much do FDA Entry Point and Assurentry cost?

FDA Entry Point costs $295 per facility per year for U.S. Agent coverage. Assurentry advertises $199 per year, but its public terms set $399 per year unless the buyer’s order provides another amount. FDA Entry Point separately publishes common filing prices, while Assurentry bundles selected work into named plans. Buyers should compare the executed annual fee, renewal price, product charges, shipment filings, cancellation terms, and any government fees. Evidence: FDA Entry Point pricing and Assurentry terms.

What does FDA Entry Point’s $295 U.S. Agent fee include?

The $295 annual fee includes U.S. Agent designation, ongoing coverage, receipt and escalation of FDA communications, inspection coordination, renewal tracking, and direct specialist support. Facility registration, product listing, Prior Notice, label review, SPL, GUDID/UDI, FSVP responsibility, and government fees are separate services. This structure makes recurring coverage predictable while keeping product- and shipment-dependent work visible. FDA Entry Point U.S. Agent services defines the included scope.

Does Assurentry offer more than a mailbox U.S. Agent?

Yes, Assurentry offers substantially more than a mailbox: guided digital onboarding, FDA communication forwarding, inspection escalation, renewal reminders, a dashboard, compliance tools, and published response targets. Its SLA is a meaningful strength, particularly for priority FDA communications and import-hold notices. The principal difference is that Assurentry organizes the relationship around its platform, while FDA Entry Point makes a human compliance team the primary interface. Assurentry’s SLA specifies its response commitments.

Which provider is better after a missed renewal or bad service?

FDA Entry Point is generally the stronger fit after a missed renewal or an unresponsive agent because its model centers on direct human accountability, proactive renewal tracking, and access to the same team for corrective registration and listing work. Assurentry also provides renewal reminders and escalation SLAs, so buyers who prefer a dashboard may still favor it. The deciding question is whether the buyer wants portal-based visibility or a named team to coordinate the recovery. FDA U.S. Agent lapse and replacement guidance explains the operational stakes.